Infos for Sustainability

The rating agency ISS ESG assesses the sustainability of companies with regard to environmental, social and corporate governance issues. These ratings are public here, where available. In addition, the company can voluntarily provide information and refer to research, reports and ratings from others. 

ESG Profile

Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, of which about 3.9 million worldwide regularly undergo dialysis. With more than 4,000 proprietary dialysis clinics in about 50 countries, we treat more than 340,000 patients globally. We have approximately 128,000 employees worldwide.  

Serving our patients is our focus, which also shapes how we integrate sustainability into our business and how we tackle global health care challenges. Our commitment to sustainability is incorporated in our mission to provide the best possible care to a growing number of patients in diverse health care systems. It is also reflected in our strategy to deliver sustainable solutions with innovative products and service of the highest quality at reliable cost.  

Managing sustainability successfully means creating lasting economic, ecological, and social value. For us, it also means driving the integration of sustainability in our business across our global business.  

More information on Fresenius Medical Care's sustainability activities: https://www.freseniusmedicalcare.com/en/sustainability  

Reporting

For an annual update on our sustainability reporting, please refer to our Non-Financial Group Report 2022 as well as our GRI Index, our TCFD Index, our SASB Index, and our ESG Performance Data. For more information on our ESG ratings performance, please visit our website.

The voluntary company information (in the sections ESG Profile, Reporting, Rating) were last updated on 30/03/2023.

Infos for Sustainability

The rating agency ISS ESG assesses the sustainability of companies with regard to environmental, social and corporate governance issues. These ratings are public here, where available. In addition, the company can voluntarily provide information and refer to research, reports and ratings from others. 

ESG Profile

Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, of which about 3.9 million worldwide regularly undergo dialysis. With more than 4,000 proprietary dialysis clinics in about 50 countries, we treat more than 340,000 patients globally. We have approximately 128,000 employees worldwide.  

Serving our patients is our focus, which also shapes how we integrate sustainability into our business and how we tackle global health care challenges. Our commitment to sustainability is incorporated in our mission to provide the best possible care to a growing number of patients in diverse health care systems. It is also reflected in our strategy to deliver sustainable solutions with innovative products and service of the highest quality at reliable cost.  

Managing sustainability successfully means creating lasting economic, ecological, and social value. For us, it also means driving the integration of sustainability in our business across our global business.  

More information on Fresenius Medical Care's sustainability activities: https://www.freseniusmedicalcare.com/en/sustainability  

Reporting

For an annual update on our sustainability reporting, please refer to our Non-Financial Group Report 2022 as well as our GRI Index, our TCFD Index, our SASB Index, and our ESG Performance Data. For more information on our ESG ratings performance, please visit our website.